SMTL ID : 6jqr.1

Crystal structure of FLT3 in complex with gilteritinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x C6F: 6-ethyl-3-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide(Non-covalent)

C6F.1: 11 residues within 4Å: Chain A: L.46, A.72, V.105, E.122, Y.123, C.124, C.125, G.127, D.128, L.197, F.209 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.46, A:Y.123 Hydrogen bonds: A:E.122, A:C.124, A:C.124

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 8 residues within 4Å: Chain A: E.34, F.35, P.36, R.37, C.111, T.112, L.113, S.114 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:F.35, A:R.37, A:T.112, A:L.113, A:S.114 Salt bridges: A:R.37 SO4.3: 4 residues within 4Å: Chain A: R.134, N.220, N.266 Ligands: CXS.7 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.220, A:N.266 Water bridges: A:R.134 Salt bridges: A:R.134 SO4.4: 3 residues within 4Å: Chain A: Y.126, H.200, G.201 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.126, A:G.201 Salt bridges: A:H.200

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.5: 2 residues within 4Å: Chain A: K.32, W.33 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.32 Water bridges: A:I.62, A:L.108 GOL.6: 5 residues within 4Å: Chain A: K.286, A.306, F.307, D.308, K.311 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:K.286, A:F.307, A:D.308, A:K.311 Water bridges: A:W.305 GOL.8: 1 residues within 4Å: Chain A: N.276 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.276

1 x CXS: 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID(Non-covalent)

CXS.7: 6 residues within 4Å: Chain A: R.134, R.137, G.264, V.265, N.266 Ligands: SO4.3 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.266 Salt bridges: A:R.134, A:R.137

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kawase, T. et al., Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells. Oncotarget (2019)

Release Date

2019-11-20

Peptides

Receptor-type tyrosine-protein kinase FLT3,Receptor-type tyrosine-protein kinase FLT3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Receptor-type tyrosine-protein kinase FLT3,Receptor-type tyrosine-protein kinase FLT3